↓ Skip to main content

Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM)

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015
Altmetric Badge

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM)
Published in
Journal for Immunotherapy of Cancer, November 2015
DOI 10.1186/2051-1426-3-s2-p259
Authors

Réjean Lapointe, Rahima Jamal, Leon van Kempen, Pamela Thebault, Karl Belanger, Jennifer Friedmann, Jean-Pierre Ayoub, Eftihia Cocolakis, Shirin Kazemi, Jeanne Dionne, Caroline Lambert, Huy Le, Cecile Grange, Jean-Francois Cailhier, Alan Spatz, Wilson Miller

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 17%
Student > Ph. D. Student 1 17%
Student > Postgraduate 1 17%
Other 1 17%
Unknown 2 33%
Readers by discipline Count As %
Medicine and Dentistry 2 33%
Immunology and Microbiology 1 17%
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Unknown 2 33%